Loading clinical trials...
Loading clinical trials...
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Grenoble
NCT06997796 · Epistaxis Nosebleed
NCT07421622 · Epistaxis Nosebleed, Greater Palatine Foramen
NCT04646356 · Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed
NCT06651840 · Epistaxis Nosebleed
NCT02517294 · Epistaxis
CHU Grenoble Alpes
La Tronche, ISERE
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions